CN1218721C - Chinese medicine proprietary for treating cerebrovascular and cardiovascular disease - Google Patents
Chinese medicine proprietary for treating cerebrovascular and cardiovascular disease Download PDFInfo
- Publication number
- CN1218721C CN1218721C CN 02135862 CN02135862A CN1218721C CN 1218721 C CN1218721 C CN 1218721C CN 02135862 CN02135862 CN 02135862 CN 02135862 A CN02135862 A CN 02135862A CN 1218721 C CN1218721 C CN 1218721C
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- blood
- present
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses Chinese patent medicine for treating cerebrovascular diseases and cardiovascular diseases. The present invention is prepared from 23 kinds of Chinese herbal medicine such as fleeceflower root, prepared rhizome of rehmannia, rehmannia root, radix asparagi, ophiopogon root, angelica, eucommia bark, desertliving cistanche, medlar, longspur epimedium, Chinese magnolivine fruit, dodder, polygala, radix dipsaci from Sichuan of China, oriental arborvitae, common cnidium fruit, white atractylodes rhizome, double blossom, scrophularia, Chinese arborvitae kernel, cassia bark, rhizome, ginseng, white peony alba, tuckahoe, water plantain, bupleurum root, red sage root, ledebouriella root, coix, saffron, hemlock parsley, slenderstyle acanthopanax bark, etc. The present invention has a recipe principle of tonifying qi and blood, promoting the blood circulation, expelling blood impediment, activating blood circulation to dissipate blood stasis and eliminating evil for dredging channels, and the recipe principle of the present invention conforms to the pathogenic mechanism recognition and a therapeutic principle on the cerebrovascular diseases and the cardiovascular diseases by traditional Chinese medicine. The present invention has the advantages of convenient administration, conspicuous curative effect, no position on human bodies, harmlessness and no side effect.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of cardiovascular and cerebrovascular disease, relating in particular to a kind of is the Chinese patent medicine of the treatment cardiovascular and cerebrovascular disease of feedstock production with the Chinese herbal medicine.
Background technology
Cardiovascular and cerebrovascular disease mainly comprises diseases such as hypertension, heart disease, cerebral hemorrhage, cerebral thrombosis, and such disease is a kind of common multiple disease, and it seriously influences patient's physical and mental health and daily life.
At present clinical treatment of diseases such as hypertension, heart disease, cerebral hemorrhage roughly are divided into: strong blood pressure lowering, blood vessel dilating, blood circulation promoting and blood stasis dispelling, means such as dispel the wind.The weak point that exists is:
1, to hypertensive treatment based on Western medicine, most of depressor can only play the effect of temporary transient blood pressure lowering, blood pressure can raise again after the drug withdrawal; 2, all be by temporary transient symptomatic treatment such as heart tonifying, coronary artery dilator to cardiopathic therapeutic modality, can only play mitigation; 3, the medicament scope of suiting the medicine to the illness is narrow, and a disease will be taken multiple relevant medicine, can not comprehensive therapy; 4, single disease is singly controlled, and does not consider other factors.
Summary of the invention
Purpose of the present invention is intended to overcome above-mentioned shortcoming, and the Chinese patent medicine of the treatment cardiovascular and cerebrovascular disease that a kind of curative effect is fast, effect is lasting, have no side effect is provided.
For reaching above-mentioned purpose, solution of the present invention is to pathogenetic understanding of cardiovascular and cerebrovascular disease and Therapeutic Principle according to the traditional Chinese medical science, with reference to the modern pharmacological research achievement, and clinical practice for many years, from motherland's medical treasure-house, filter out fill blood, promoting blood circulation, by the natural Chinese medicinal herb of arthralgia due to stagnation of blood, blood circulation promoting and blood stasis dispelling, eliminating evil collateral dredging, by traditional Chinese medical science prescription theory, make oral Chinese patent medicine.
Chinese patent medicine of the present invention is made by following Chinese medicine raw materials by weight proportion:
Radix Polygoni Multiflori 47-57 Radix Rehmanniae Preparata 27-33 Radix Rehmanniae 27-33 Radix Asparagi 27-33
Radix Ophiopogonis 27-33 Radix Angelicae Sinensis 47-57 Cortex Eucommiae 47-57 Herba Cistanches 27-33
Fructus Lycii 27-33 Herba Epimedii 36-42 Fructus Schisandrae Chinensis 47-57 Semen Cuscutae 27-33
Radix Polygalae 27-33 Radix Dipsaci 47-57 Cacumen Platycladi 47-57 Fructus Cnidii 47-57
Rhizoma Atractylodis Macrocephalae 13-17 Flos Lonicerae 27-33 Radix Scrophulariae 27-33 Semen Platycladi 27-33
Cortex Cinnamomi 8-10 Rhizoma Dioscoreae 27-33 Radix Ginseng 7-9 Radix Paeoniae Alba 16-20
Poria 27-33 Rhizoma Alismatis 27-33 Radix Bupleuri 16-20 Radix Salviae Miltiorrhizae 18-22
Radix Saposhnikoviae 13-17 Semen Coicis 27-33 Stigma Croci 18-22 Rhizoma Chuanxiong 18-22
Cortex Acanthopancis 23-27
Above-mentioned Chinese medicine raw materials by weight proportion is made oral Chinese patent medicine.
The optimum weight proportioning of each raw material of Chinese medicine of Chinese patent medicine of the present invention is:
Radix Polygoni Multiflori 52 Radix Rehmanniaes Preparata 30 Radix Rehmanniae 30 Radix Asparagis 30
Radix Ophiopogonis 30 Radix Angelicae Sinensis, 52 Cortexs Eucommiae, 52 Herba Cistanches 30
Fructus Lycii 30 Herba Epimedii 39 Fructus Schisandrae Chinensis 52 Semen Cuscutae 30
Radix Polygalae 30 Radix Dipsaci 52 Cacumen Platycladis 52 Fructus Cnidiis 52
The Rhizoma Atractylodis Macrocephalae 15 Flos Loniceraes 30 Radix Scrophulariae 30 Semen Platycladi 30
Cortex Cinnamomi 9 Rhizoma Dioscoreaes 30 Radix Ginsengs 8 Radix Paeoniae Albas 18
Poria 30 Rhizoma Alismatis 30 Radix Bupleuri 18 Radix Salviae Miltiorrhizaes 20
Radix Saposhnikoviae 15 Semen Coiciss 30 Stigma Crocis 20 Rhizoma Chuanxiongs 20
Cortex Acanthopancis 25
Above-mentioned Chinese medicine raw materials by weight proportion is made the oral Chinese patent medicine of honeyed pill dosage form.
The inventor thinks that the cause of disease of cardiovascular and cerebrovascular disease is: hypertension lacks physical exertion with long-term psychentonia, family history of hypertension is arranged, in the overweight, diet the overweight and a large amount of smokings of Sal relevant; The primary disease pathogeny, theory is numerous, it is generally acknowledged that the higher nervous center dysfunction occupies an leading position in morbidity; Body fluid, endocrine factors, kidney etc. also participate in pathogenic process.Heart disease is many by the deficiency of vital energy, blood deficiency, caused by energy stagnation and blood stasis.Cerebral hemorrhage belongs to acute disease, is that the focal disturbance of blood circulation of brain that the pathological changes of neck arteries because of brain or supply brain causes causes disturbance of consciousness and the focal symptom of brain; Long-term hypertension causes cerebral arteries to break, the sequela that stays after rescuing, hemiplegia, aphasis etc.The embolus of cerebral thrombosis easily plays coming off of wall thrombosis and waits all thrombosis to come off mainly from various heart diseases, enters entocranial artery blood, all can invite to cause cerebral embolism.
Based on above-mentioned consideration, the inventor consults amount of literature data and for many years clinical practice, determines that " fill blood, promoting blood circulation, by arthralgia due to stagnation of blood, blood circulation promoting and blood stasis dispelling, eliminating evil collateral dredging " is the principles of formulating prescriptions.
Radix Polygoni Multiflori invigorating the liver and kidney, benefiting essence-blood in the prescription of the present invention; The Radix Rehmanniae Preparata nourishing YIN and supplementing blood; Radix Rehmanniae clearing away heat and nourishing YIN, removing heat from blood are moisturized; Radix Asparagi nourishing YIN to relieve dryness, clearing away lung-heat to relieve cough; Radix Ophiopogonis clearing away heart-fire and moistening the lung, nourishing the stomach to promote the production of body fluid; Chinese angelica blood supplementing, invigorate blood circulation, regulating menstruation, intestine moistening; Cortex Eucommiae invigorating the liver and kidney, strengthening bone and muscle, blood pressure lowering; Herba Cistanches kidney invigorating and YANG supporting, intestine moistening can be just; Fructus Lycii the kidney invigorating and essence nourishing, nourishing the liver to improve visual acuity; Herba Epimedii the kidney warming rib sun, expelling wind and removing dampness; Fructus Schisandrae Chinensis astringe the lung nourishing kidney, the hidroschesis that promotes the production of body fluid, calm the nerves; Semen Cuscutae the kidney invigorating and essence nourishing, nourishing the liver to improve visual acuity; Radix Polygalae calm the nerves strong will, expelling phlegm for arresting cough; Radix Dipsaci invigorating the liver and kidney, bone and muscle strengthening, continuous folding are hindered, blood circulation regulating; Cacumen Platycladi cooling blood for hemostasis, expelling phlegm for arresting cough, remove rheumatism, lung, dry soil are grown in yin nourishing; Fructus Cnidii warming the kidney to activate YANG, removing dampness and killing parasites; Rhizoma Atractylodis Macrocephalae spleen invigorating and in, the dampness diuretic; The Flos Lonicerae heat-clearing and toxic substances removing; Radix Scrophulariae heat clearing away YIN nourishing, eliminating fire and detoxication; Semen Platycladi tranquilizing by nourishing the heart, intestine moistening can be just; Cortex Cinnamomi kidney-replenishing, warming the spleen and stomach, removing accumulated cold, energy blood vessels; Rhizoma Dioscoreae clearing away heart-fire and moistening the lung, nourishing the stomach to promote the production of body fluid; Ginseng qi-tonifying takes off admittedly, tonifying the lung strengthening the spleen, promoting the production of body fluid and inducing sedation of the mind; The Radix Paeoniae Alba nourish blood yin fluid astringing, easing the affected liver to relieve pain; Poria promoting diuresis to eliminate damp pathogen, invigorating the spleen and regulating the stomach, mind tranquilizing and the heart calming; The Rhizoma Alismatis promoting diuresis to eliminate damp pathogen, expel the heat-evil; Radix Bupleuri reconciling superficies and interior, soothing the liver yang invigorating; Radix Salviae Miltiorrhizae blood circulation promoting and blood stasis dispelling, calming heart and tranquilizing mind; Radix Saposhnikoviae expelling wind and dampness, pain relieving; Semen Coicis strengthening the spleen and tonifying the lung, clearing away heat-damp and promoting diuresis; Stigma Croci invigorate blood circulation moisturize, pain-relieving powder for treating is swollen; Rhizoma Chuanxiong repercussive blood, tonifying liver blood, dry, the benefit wind void of profit liver; Cortex Acanthopancis wind-damp dispelling, hard muscles and bones.Above-mentioned 33 flavor medicines are worked in coordination, and play the effect of " fill blood, promoting blood circulation, by arthralgia due to stagnation of blood, blood circulation promoting and blood stasis dispelling, eliminating evil collateral dredging " jointly, meet the traditional Chinese medical science to pathogenetic understanding of cardiovascular and cerebrovascular disease and Therapeutic Principle.
For showing therapeutic effect of the present invention, add up as follows with the clinical efficacy situation of Chinese patent drugs for treatment 100 routine various cardiovascular and cerebrovascular diseases of the present invention:
One, case is selected:
Disease | Case load | The man | The woman | The crowd | Number | The crowd | Number | The crowd | Number |
Hypertension | 30 | 10 | 20 | The man is more than 70 years old | 5 | 50-70 year | 5 | ||
The woman is more than 70 years old | 10 | 50-70 year | 5 | 40-50 year | 5 | ||||
Heart disease | 20 | 10 | 10 | The man is more than 60 years old | 6 | 40-60 year | 4 | ||
The woman is more than 60 years old | 5 | 40-60 year | 5 | ||||||
Cerebral hemorrhage | 25 | 15 | 10 | The man is more than 50 years old | 10 | 40-50 year | 5 | ||
The woman is more than 50 years old | 7 | 40-50 year | 3 | ||||||
Cerebral thrombosis | 25 | 15 | 10 | The man is more than 50 years old | 10 | 40-50 year | 5 | ||
The woman is more than 50 years old | 8 | 40-50 year | 2 |
Two, Therapeutic Method:
To being diagnosed as the patient of cardiovascular and cerebrovascular disease, giving Chinese patent medicine of the present invention and take, seriously ill person every day three times, each ball (4-6 gram); Sick the lighter every day twice, each ball (4-6 gram).Per 30 days is a course of treatment, takes three courses of treatment continuously.
Three, treatment standard:
Produce effects: clinical symptom disappearance, functional rehabilitation is normal.Drug withdrawal was not seen the recidivist more than 1 year.
Effectively: clinical symptom relief, focus is basicly stable, observes person more than month.
Invalid: clinical symptoms does not have obvious improvement.
Four, curative effect statistics:
Disease | Case load | Produce effects | Effectively | Invalid | Effective percentage |
Hypertension | 30 | 18 | 11 | 1 | 96.7% |
Heart disease | 20 | 13 | 6 | 1 | 95% |
Cerebral hemorrhage | 25 | 16 | 8 | 1 | 96% |
Cerebral thrombosis | 25 | 12 | 12 | 1 | 96% |
By above-mentioned clinical data as seen, Chinese patent medicine of the present invention all has better curative effect to various types of cardiovascular and cerebrovascular diseases, treating both the principal and secondary aspects of a disease, and effective percentage reaches 96%.
The present invention has following advantage:
1, the present invention selects for use natural Chinese medicinal herb to be raw material, and is nontoxic to human body, has no side effect.
2, the present invention need not decoct, and treatment is convenient, and effective percentage reaches 96%.
3, prescription of the present invention meets the traditional Chinese medical science to pathogenetic understanding of cardiovascular and cerebrovascular disease and Therapeutic Principle, and clothes of a specified duration can make us making light of one's life by commiting suicide not old, and the sliding pool of human body is fair and clear, safeguards the intravital ecological balance of people, reaches the purpose of disease-relieving and physique enhancing.
The specific embodiment
Embodiment 1: present embodiment is made by the following weight Chinese medicinal raw materials:
Radix Polygoni Multiflori 52kg Radix Rehmanniae Preparata 30kg Radix Rehmanniae 30kg Radix Asparagi 30kg
Radix Ophiopogonis 30kg Radix Angelicae Sinensis 52kg Cortex Eucommiae 52kg Herba Cistanches 30kg
Fructus Lycii 30kg Herba Epimedii 39kg Fructus Schisandrae Chinensis 52kg Semen Cuscutae 30kg
Radix Polygalae 30kg Radix Dipsaci 52kg Cacumen Platycladi 52kg Fructus Cnidii 52kg
Rhizoma Atractylodis Macrocephalae 15kg Flos Lonicerae 30kg Radix Scrophulariae 30kg Semen Platycladi 30kg
Cortex Cinnamomi 9kg Rhizoma Dioscoreae 30kg Radix Ginseng 8kg Radix Paeoniae Alba 18kg
Poria 30kg Rhizoma Alismatis 30kg Radix Bupleuri 18kg Radix Salviae Miltiorrhizae 20kg
Radix Saposhnikoviae 15kg Semen Coicis 30kg Stigma Croci 20kg Rhizoma Chuanxiong 20kg
Cortex Acanthopancis 25kg
Preparation method: take by weighing the raw material of respectively distinguishing the flavor of by prescription, choose only, dry, be ground into meticulous, be smelt honeyed pill according to a conventional method, every ball weighs 4 grams.
Function with cure mainly: fill blood, promoting blood circulation, by arthralgia due to stagnation of blood, blood circulation promoting and blood stasis dispelling, eliminating evil collateral dredging.Be used for cardiovascular and cerebrovascular diseases such as hypertension, heart disease, cerebral hemorrhage, cerebral thrombosis.
Usage and consumption: seriously ill person every day three times, each ball; Sick the lighter every day twice, each ball; Old long-term user, every day is each ball sooner or later.
Taboo: cancer patient, anemia of pregnant woman prohibit clothes.
Storage: blow-by can be preserved 2-4 month under the room temperature, and sealing can be preserved more than 2 years.
Embodiment 2: present embodiment is made by the following weight Chinese medicinal raw materials:
Radix Polygoni Multiflori 47kg Radix Rehmanniae Preparata 27kg Radix Rehmanniae 27kg Radix Asparagi 27kg
Radix Ophiopogonis 27kg Radix Angelicae Sinensis 47kg Cortex Eucommiae 47kg Herba Cistanches 27kg
Fructus Lycii 27kg Herba Epimedii 36kg Fructus Schisandrae Chinensis 47kg Semen Cuscutae 27kg
Radix Polygalae 27kg Radix Dipsaci 47kg Cacumen Platycladi 47kg Fructus Cnidii 47kg
Rhizoma Atractylodis Macrocephalae 13kg Flos Lonicerae 27kg Radix Scrophulariae 27kg Semen Platycladi 27kg
Cortex Cinnamomi 8kg Rhizoma Dioscoreae 27kg Radix Ginseng 7kg Radix Paeoniae Alba 16kg
Poria 27kg Rhizoma Alismatis 27kg Radix Bupleuri 16kg Radix Salviae Miltiorrhizae 18kg
Radix Saposhnikoviae 13kg Semen Coicis 27kg Stigma Croci 18kg Rhizoma Chuanxiong 18kg
Cortex Acanthopancis 23kg
Above-mentioned Chinese medicine raw materials by weight proportion is made the oral Chinese patent medicine of honeyed pill dosage form.
Embodiment 3: present embodiment is made by the following weight Chinese medicinal raw materials:
Radix Polygoni Multiflori 57kg Radix Rehmanniae Preparata 33kg Radix Rehmanniae 33kg Radix Asparagi 33kg
Radix Ophiopogonis 33kg Radix Angelicae Sinensis 57kg Cortex Eucommiae 57kg Herba Cistanches 33kg
Fructus Lycii 33kg Herba Epimedii 42kg Fructus Schisandrae Chinensis 57kg Semen Cuscutae 33kg
Radix Polygalae 33kg Radix Dipsaci 57kg Cacumen Platycladi 57kg Fructus Cnidii 57kg
Rhizoma Atractylodis Macrocephalae 17kg Flos Lonicerae 33kg Radix Scrophulariae 33kg Semen Platycladi 33kg
Cortex Cinnamomi 10kg Rhizoma Dioscoreae 33kg Radix Ginseng 9kg Radix Paeoniae Alba 20kg
Poria 33kg Rhizoma Alismatis 33kg Radix Bupleuri 20kg Radix Salviae Miltiorrhizae 22kg
Radix Saposhnikoviae 17kg Semen Coicis 33kg Stigma Croci 22kg Rhizoma Chuanxiong 22kg
Cortex Acanthopancis 27kg
Above-mentioned Chinese medicine raw materials by weight proportion is made the oral Chinese patent medicine of honeyed pill dosage form.
Claims (2)
1, a kind of oral Chinese patent medicine for the treatment of cardiovascular and cerebrovascular disease, it is characterized in that: it is made by following Chinese medicine raw materials by weight proportion:
Radix Polygoni Multiflori 47-57 Radix Rehmanniae Preparata 27-33 Radix Rehmanniae 27-33 Radix Asparagi 27-33
Radix Ophiopogonis 27-33 Radix Angelicae Sinensis 47-57 Cortex Eucommiae 47-57 Herba Cistanches 27-33
Fructus Lycii 27-33 Herba Epimedii 36-42 Fructus Schisandrae Chinensis 47-57 Semen Cuscutae 27-33
Radix Polygalae 27-33 Radix Dipsaci 47-57 Cacumen Platycladi 47-57 Fructus Cnidii 47-57
Rhizoma Atractylodis Macrocephalae 13-17 Flos Lonicerae 27-33 Radix Scrophulariae 27-33 Semen Platycladi 27-33
Cortex Cinnamomi 8-10 Rhizoma Dioscoreae 27-33 Radix Ginseng 7-9 Radix Paeoniae Alba 16-20
Poria 27-33 Rhizoma Alismatis 27-33 Radix Bupleuri 16-20 Radix Salviae Miltiorrhizae 18-22
Radix Saposhnikoviae 13-17 Semen Coicis 27-33 Stigma Croci 18-22 Rhizoma Chuanxiong 18-22
Cortex Acanthopancis 23-27.
2, the oral Chinese patent medicine of treatment cardiovascular and cerebrovascular disease according to claim 1 is characterized in that: it is the honeyed pill that following column weight amount Chinese medicinal raw materials is made:
Radix Polygoni Multiflori 52 Radix Rehmanniaes Preparata 30 Radix Rehmanniae 30 Radix Asparagis 30
Radix Ophiopogonis 30 Radix Angelicae Sinensis, 52 Cortexs Eucommiae, 52 Herba Cistanches 30
Fructus Lycii 30 Herba Epimedii 39 Fructus Schisandrae Chinensis 52 Semen Cuscutae 30
Radix Polygalae 30 Radix Dipsaci 52 Cacumen Platycladis 52 Fructus Cnidiis 52
The Rhizoma Atractylodis Macrocephalae 15 Flos Loniceraes 30 Radix Scrophulariae 30 Semen Platycladi 30
Cortex Cinnamomi 9 Rhizoma Dioscoreaes 30 Radix Ginsengs 8 Radix Paeoniae Albas 18
Poria 30 Rhizoma Alismatis 30 Radix Bupleuri 18 Radix Salviae Miltiorrhizaes 20
Radix Saposhnikoviae 15 Semen Coiciss 30 Stigma Crocis 20 Rhizoma Chuanxiongs 20
Cortex Acanthopancis 25.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02135862 CN1218721C (en) | 2002-12-09 | 2002-12-09 | Chinese medicine proprietary for treating cerebrovascular and cardiovascular disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02135862 CN1218721C (en) | 2002-12-09 | 2002-12-09 | Chinese medicine proprietary for treating cerebrovascular and cardiovascular disease |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1422649A CN1422649A (en) | 2003-06-11 |
CN1218721C true CN1218721C (en) | 2005-09-14 |
Family
ID=4748397
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 02135862 Expired - Fee Related CN1218721C (en) | 2002-12-09 | 2002-12-09 | Chinese medicine proprietary for treating cerebrovascular and cardiovascular disease |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1218721C (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1327882C (en) * | 2004-10-13 | 2007-07-25 | 于云龙 | Traditional Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease |
CN101278744B (en) * | 2008-05-16 | 2011-04-06 | 孙平贵 | Health care sea shrimp capable of preventing cardiovascular and cerebrovascular diseases |
CN101406677B (en) * | 2008-11-26 | 2011-01-12 | 河南省宛西制药股份有限公司 | Medicinal liquor having function for warming and invigorating kidney yang |
CN103656495B (en) * | 2013-11-26 | 2016-01-06 | 张雅静 | Salvia miltiorrhiza phytic acid electuary |
CN104800450A (en) * | 2015-05-11 | 2015-07-29 | 吴杰 | Medicine for treating cranial nerve and cerebrovascular diseases |
CN105079435A (en) * | 2015-05-17 | 2015-11-25 | 王兰英 | Traditional Chinese medicine composition for treating hypertension |
CN105311560A (en) * | 2015-08-28 | 2016-02-10 | 蒋东晓 | Traditional Chinese medicine for treating cerebral hemorrhage |
CN106822660A (en) * | 2017-04-05 | 2017-06-13 | 王振 | A kind of Chinese medicine preparation for treating cardiovascular and cerebrovascular disease |
-
2002
- 2002-12-09 CN CN 02135862 patent/CN1218721C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1422649A (en) | 2003-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1095610A (en) | The pharmaceutical preparation Fubingkang of treatment, prevention gynecological diseases | |
CN1485083A (en) | Capsule for thyroid cancer / tumor and lymph node | |
CN1562160A (en) | Composite medicine for treating hepatitis B complication | |
CN102430079B (en) | Traditional Chinese medicine composite for treating stranguria | |
CN102327390B (en) | Formula for Chinese medicine for preventing and treating chemotherapeutic toxic and side reaction and preparation method for Chinese medicinal pills | |
CN1066788A (en) | The method for making of body-strengthening nutrient oral liquid and purposes in the Asia | |
CN102614442B (en) | Traditional Chinese drug capsules with effects of immunity enhancing, blood reinforcing and antiemesis | |
CN1660395A (en) | Formula of treating apoplexy | |
CN103142865A (en) | Traditional Chinese medicine for treating hypertension | |
CN1218721C (en) | Chinese medicine proprietary for treating cerebrovascular and cardiovascular disease | |
CN103599496A (en) | Traditional Chinese medicine for treatment of chronic gastritis | |
CN104013769A (en) | Traditional Chinese medicine oral solution for treating osteoporosis | |
CN1049827C (en) | Anti-cancer powder | |
CN106421432A (en) | Traditional Chinese medicine for treating aged body deficiency syndrome and delaying senescence | |
CN1364628A (en) | Compound Chinese medicinal preparation for treating chronic diarrhea-chronic Xiehanning pill | |
CN105148171A (en) | Weight-reducing medicine | |
CN102327572A (en) | Chinese medicament for invigorating primordial energy and treating gastroptosis and extraction method thereof | |
CN1237443A (en) | Medicine for curing rheumatic heart disease | |
CN1562208A (en) | Medication for treating malignant tumor and preparation method | |
CN101049374A (en) | Oral liquid for treating leucoderma, and preparation method | |
CN105213766B (en) | A kind of dredging collateral supports knee soup and preparation method thereof | |
CN1156567C (en) | Body-building 'Dugui' wine | |
CN1055220C (en) | Chinese drug for treatment of hemiplegia | |
CN103495103B (en) | Medicament for promoting digestion and strengthening spleen | |
CN1253196C (en) | Medicine for treating colitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050914 Termination date: 20111209 |